• CONCLUSION: Substantial BMO-MRW loss appears to be necessary for VF loss to be detectable in patients with open angle glaucoma with standard achromatic perimetry.
INTRODUCTION
G laucoma is a chronic optic neuropathy characterized by the progressive decrease of retinal ganglion cells (RGCs) and their axons, resulting in thinning of the neuroretinal rim of the optic nerve head (ONH) and retinal nerve fiber layer (RNFL), and eventually leading to visual field (VF) defects [1] . The diagnosis of glaucoma and the detection of progression are based on a combination of structural and functional tests [2] [3] . However, discordance between structural and functional testing should be expected in patients with glaucoma [4] [5] .
Optic disc damage and RNFL defects may precede the beginning of glaucomatous VF loss [6] [7] . Kerrigan-Baumrind et al [8] reported that a 25%-35% RGC loss was associated with statistical abnormalities in automated VF testing. Other studies have reported that a 8%-42% RNFL loss, as measured using spectral-domain optical coherence tomography (SD-OCT), was required for functional loss to be detectable [9] [10] .
Most importantly, detection of early structural changes that can precede VF loss is fundamental to the long-term preservation of vision in glaucoma patients [6] [7] [8] [9] [10] . The SD-OCT enabled clinicians to characterize the ONH anatomy in relation to the clinical optic disc margin [11] .
Recently, Reis et al [12] introduced a new anatomical parameter of neuroretinal rim, Bruch's membrane opening-minimum rim width (BMO-MRW), which quantifies the neuroretinal rim from BMO's inner end and accounts for the variable trajectory of RGC axons at the measurement points. This parameter consists of the shortest distance between the BMO and the internal limiting membrane (ILM), and has been reported to yield better diagnostic accuracy and more accurate structurefunction relationship than the disc margin-based rim area [13] [14] [15] [16] . However, none of these studies identified the threshold value of the BMO-MRW at which the functional loss as measured with standard automated perimetry can be detected. Therefore, the purpose of this study was to determine the BMO-MRW tipping point at which the VF loss was detectable and related to structural changes. SUBJECTS AND METHODS Participants In this retrospective, cross-sectional study, open angle glaucoma patients and normal subjects who were seen at the Glaucoma Clinic at Pusan National University Hospital between August 1, 2015 and January 31, 2016 were included. The study was conformed to the tenets of the Declaration of Helsinki and was approved by the Institutional Review Board (IRB) of Pusan National University Hospital. The written consent from patients was waived by IRB because this is a retrospective, anonymous study. When both eyes of a participant were eligible, one eye was randomly chosen for inclusion in the study. All of the enrolled glaucoma patients and healthy subjects underwent a complete ophthalmic examination, including measurement of the best-corrected visual acuity (BCVA), a slit-lamp examination, gonioscopy, funduscopy, biometry using an IOL Master (Carl Zeiss Meditec, Dublin, CA, USA), and standard automated perimetry. Central corneal thickness was measured using ultrasonic pachymetry (Pachmate; DGH Technology, Exton, PA, USA). Keratometry and spherical equivalent were measured with an Auto Kerato-Refractometer (ARK-510A; NIDEK, Hiroishi, Japan). All of the patients were also examined using red-free RNFL photographs, optic disc stereoscopic photographs, and SD-OCT images (Spectralis; Heidelberg Engineering, Heidelberg, Germany). The inclusion criteria for the participants included an age >18y with a clear cornea and clear ocular media, a BCVA≥20/40, a refractive error within ±6.0 diopters (D) of 0, and astigmatism ±3.0 D of 0. Exclusion criteria included diabetes, uveitis, secondary glaucoma, corneal abnormalities, non-glaucomatous optic neuropathies, previous trauma, ocular surgery or laser treatment, or any other eye disease other than glaucoma. Eyes were classified as having open angle glaucoma if they had a glaucomatous optic disc and two consecutive abnormal VF test results with open angles on gonioscopy. Glaucomatous optic neuropathy was defined as having a >0.2 cup-to-disc ratio asymmetry between the two eyes, neuroretinal rim thinning, notching, or characteristic RNFL defects indicative of glaucoma [17] . Healthy subjects were recruited among those who visited this hospital for regular health check-ups or refractive errors. They were defined as those with no history of ocular disease, an intraocular pressure <21 mm Hg, an absence of glaucomatous optic disc appearance, and a normal VF. Subjects who were clinically suspected to have glaucoma because of ONH or RNFL appearance, or elevated intraocular pressure but with normal VF were included in the healthy subjects to ensure representation of the full spectrum of disease. Perimetric Tests All VF tests were performed with an automated VF analyzer (Humphrey Field Analyzer; Carl Zeiss Meditec, Inc., Dublin, CA, USA) with a 24-2 pattern and a size III white stimulus using the Swedish Interactive Threshold Algorithm (SITA) standard strategy. Reliable tests were defined as <20% fixation loss rate, <15% false-positive rate, and <33% false-negative rate. Normal subjects had a Glaucoma Hemifield Test (GHT) within normal limits and a mean deviation (MD) and pattern standard deviation (PSD) within 95% of HFA's normative database. An abnormal VF was defined as P<0.05 for the PSD or a GHT result outside of the normal limits. The total deviation (TD) values were recorded in all of the 52 testing points (points matching the blind spot were excluded) and then assigned to the corresponding VF sector according to the GarwayHeath distribution map [18] . The TD values in dB unit was first converted to linear (1/Lambert) scale with the following formula; 1/Lambert =10 dB/10
, then averaged in each sector, and converted back to the decibel scale for analysis [19] (Figure 1 ).
Spectral-domain Optical Coherence Tomography Imaging
SD-OCT was performed on all of the subjects on the same day as the perimetric test. Scans were acquired according to the participant's specific fovea-BMO axis to minimize the geometrical errors [15] , and the data were sectorized according to this axis. The fovea position was manually located with a live B-scan, followed by the two BMO points in each of two radial B-scans that were perpendicular to each other. A radial pattern containing 24 angular, equidistant, high-resolution 15° B-scans centered on the BMO was used to compute the neuroretinal rim parameters. Each B-scan was averaged from 25 individual scans with 1536 A-scans per B-scan with a scanning speed of 40 000 A-scans per second [10, 20] . The BMO points and ILM were identified and marked in each B-scan with automated software (Glaucoma Module Premium Edition, version 6.0; Heidelberg Engineering) and corrected when necessary. Eyes with an image quality score <20 were excluded. BMO-MRW, the minimum distance between the BMO and ILM, was automatically computed globally and sectorally according to the Garway-Heath distribution map corresponding to the VF sectors [18] . The Spectralis OCT used TruTrack™ that used dual beam technology to compensation for eye motion [10, 20] . One beam captured an image of the retina and mapped over 1000 points to track eye movement. With this map as a reference, the second beam was directed to the desired location despite of eye movements.
Statistical Analysis
The normality of the data distribution was checked using the Kolmogorov-Smirnov test. Clinical characteristics of the study population were compared using Student's t-test or the Mann-Whitney U test for continuous variables, and the χ 2 test for categorical variables.
A scatterplot of the BMO-MRWs with the VF TD values showed a plateau of the VF at high BMO-MRW values and a steep decrease at lower BMO-MRW values. A nonlinear "broken stick" statistical model was used to fit this scatter plot. An initial estimate of the tipping point was determined using Davies' test [21] , after which segment regression analyses were performed with this initial tipping point as a starting value. Using iteration of segment regression analyses to reduce error, the final tipping point and two slopes of the broken stick model with their corresponding 95% confidence intervals (CIs) were determined. All of the statistical analyses were performed using R language software (http://www.R-project.org) and the segmented R library [22] . A value of P<0.05 was considered statistically significant. RESULTS One hundred sixty-eight participants (85 normal and 83 glaucoma subjects) were enrolled in the study. The demographic, clinical, and ocular characteristics of the participants are summarized in Table 1 . The global BMO-MRW of the glaucoma patients was significantly thinner than that of the normal subjects, 256.3±48.9 µm for the normal subjects and 163.8±37.9 µm for the glaucoma patients (P<0.001). The number of glaucoma patients whose sectoral BMO-MRW values followed the ISNT rule was significantly lower than the normal subjects, with 31 (36.5%) for the normal subjects and 3 (3.6%) for the glaucoma patients (P<0.001; Table 2 ). The global indices of the VF for glaucoma patients were significantly worse than the normal subjects. The VF MD was -1.22±1.91 dB for the normal subjects and -7.06±5.38 dB for glaucoma patients (P<0.001). Scatterplots of the global, sectoral BMO-MRWs and corresponding VF TD values are shown in Figures 2 and 3 . A range of BMO-MRW values was unrelated to the VF TD values, followed by a range of BMO-MRW values which was strongly related to the VF TD values (Figure 2A) . Statistically optimal locations of the tipping points between these two ranges in the global and sectoral BMO-MRW values are summarized in Table 3 . The locations of the tipping points were statistically significant for all of the locations (all P≤0.006; Davies' test). The percentages of BMO-MRW loss for the tipping points were calculated for the global and sectoral BMO-MRW values using the mean BMO-MRW values for the normal subjects. The tipping point for the global BMO-MRW measurement occurred after a 25.9% loss from the mean normal BMO-MRW value. Using sectoral analyses, the percentage of BMO-MRW loss was highest for the superonasal sector (34.9%) and was lowest loss for the temporal sector (6.6%), with a range of 8.9%-34.4% for all of the other sectors ( Table 3) . The slopes for VF TD values as a function of BMO-MRWs above and below the tipping points and the differences between the slopes are summarized in Table 4 . Above the tipping points, the slopes of the VF TD values to BMO-MRW values were not different from zero (i.e. the 95%CIs included zero) throughout was met when the BMO-MRW was thickest based on the average of the two inferior quadrants, followed by the average of the two superior, nasal, and then temporal quadrants. BMO-MRW: Bruch's membrane opening-minimum rim width. between the slopes (P<0.001; Figure 2B ). A similar segmented structure-function relationship was found using the visual field index (VFI). The tipping point was 180.4 µm (95%CI, 165.7 to 195.0) with a slope above the tipping point of 0.045 dB/µm (95%CI, 0.004 to 0.087) and below the tipping point of 0.415 dB/µm (95%CI, 0.314 to 0.516), with a statistically significant difference between the slopes (P<0.001; Figure 2C ). DISCUSSION We determined the relationship between the BMO-MRW and VF sensitivity using the broken stick tipping point model. We identified the tipping point where the VF abnormality was associated with the BMO-MRW loss. Overall, the result showed that a substantial BMO-MRW loss (25.9% loss from the average normal global value) was necessary to detect the VF loss. Determination of the actual location of the expected VF loss is clinically important in preserving vision in patients with suspected or preperimetric glaucoma [9] [10] 23] . We also found that substantial BMO-MRW thinning in inferotemporal sector (33.1%) and relatively less BMO-MRW thinning in the superotemporal sector (8.9%) were necessary for the detection of the VF loss. In the temporal sector, only 6.6% of the BMO-MRW loss was necessary for the detection of the VF loss.
BMO-MRW and visual field loss
The results in this study were consistent with the earlier studies, which reported that substantial structural loss was necessary before functional VF defects became detectable [6] [7] [8] [9] [10] . Wollstein et al [9] reported that a loss >17.3% of the mean RNFL thickness was necessary for the VF defect to be detectable. The authors reported that losses of 27.8% and 25.8% of RNFL thickness in the superior and inferior quadrants, respectively, were necessary before the VF defect was detectable [9] .
Alasil et al [10] demonstrated that detectable VF defects were associated with 42.3% and 14.5% thinning of the RNFL thickness in the inferior and superior quadrants, respectively. They also found that the temporal quadrant showed the lowest percentage RNFL loss needed to detect the central VF loss [9] [10] . The normal neural rim width is thickest in the inferior region, followed by the superior, nasal and temporal regions (ISNT rule) [24] . We showed that the BMO-MRW values also followed the ISNT rule in normal subjects. It can therefore be inferred that sectors with the thicker BMO-MRW may require more structural loss for corresponding functional abnormality to be detectable [9] [10] . The number of axons passing through the temporal region of the optic disc was significantly larger than other regions because of the high concentration of thinner axons in the papillomacular bundle [9, 25] . Based on our study, this might lead to the development of VF damage after a smaller BMO-MRW loss.
In this study, the regression slopes of VF TD values to the BMO-MRW above the tipping points were not different from zero in all of the locations. These results are consistent with clinical experience and findings in the literature, suggesting that many patients may show evidence of ONH damage before functional loss such as VF is detected [7, [26] [27] . Similarly, there was a poor association of the RNFL thickness with the VF loss when the loss of RNFL thickness was not severe [9] [10] [28] [29] [30] .
Yu et al [31] found that progressive RNFL thinning strongly predicted a subsequent VF decline. We showed that the slopes of the VF TD values to the BMO-MRW below the tipping point were significantly steeper than the slopes above the tipping point for all of the locations. It is possible that a strong clinical relationship between structure and function may be detected only after the redundancy of RGC function was exhausted [32] . The reasons for the discordance in structure-function relationship in our study were likely because standard automated perimetry had higher variability than OCT during the early development of glaucoma [19, 33] . Because of the redundancy of VF sensitivity, damage occurred without showing early abnormalities [32] [33] . In addition, global indices of the VF such as MD and VFI are insensitive to localized loss [34] and less able to detect early glaucoma because of the [35] . Gardiner et al [36] reported that both structural and functional tests were associated with significant intraindividual and inter-test variability, and the weak structurefunction relationship in ocular hypertension or suspected/early glaucoma could be explained by variability in testing. Subtle rotation of eye and head tilt can skew the OCT measurement, and each sectoral mean may differ without any actual changes in the ONH [37] . However, Spectralis OCT uses TruTrack™ that uses dual beam technology to compensate for possible eye motion to reduce the measurement variability [10, 20] . Taken together, the results suggested that a combination of structural and functional assessment are very important in the evaluation of the early glaucomatous damage and disease progression in patients with glaucoma [10, 14, 33] . Recently, an anatomically and geometrically accurate rim parameter based on the BMO was reported [12] [13] 15] . This new parameter, termed the BMO-MRW, quantifies the neuroretinal rim from the actual anatomical outer border and accounts for the variable orientation of the rim tissue in ONH [12] [13] 15] .
The BMO-MRW has better diagnostic accuracy [13] and a stronger relationship to the VF than the RNFL thickness and other neuroretinal rim measurement [14] [15] . Chauhan et al [13] reported that at 95% specificity, the sensitivity of the RNFL thickness, BMO-HRW, and BMO-MRW was 70%, 51%, and 81%, respectively. Pollet-Villard et al [14] reported that the structure-function relationship with the BMO-MRW was stronger than that with either the RNFL thickness or the Cirrus high definition OCT based neuroretinal rim measures. Danthurebandara et al [15] reported that the structure-function relationship was stronger with the BMO-MRW than with the disc margin-based rim area and the BMO based horizontal rim width (BMO-HRW). Our study differed from previous studies that used a single linear or logarithmic regression model to evaluate structure-function relationship with the BMO-MRW [14] [15] . In contrast to these previous studies, our study used the broken stick tipping point model to show that the BMO-MRW had a strong association with VF loss. We also performed analyses using the MD and VFI since they are commonly used functional parameters in clinical practice. The tipping points for MD and VFI occured at a BMO-MRW value of 185.0 µm and 180.4 µm, respectively. A proportion of neuroretinal rim area may comprise nonneural rim tissue, such as glia and blood vessels [38] . A floor effect will therefore influence the structure-function relationship in advanced glaucoma [33] . A floor effect was not identified in this study, since the study sample consisted of eyes with early to moderate structural damage [10] . The main limitation of our study was its cross-sectional nature. Clinicians should be careful to apply our findings to individual patients longitudinally. Patients may start with a thinner or thicker BMO-MRW, and their individual tipping points may differ from the value we reported. Another limitation was that the average normal BMO-MRW values were calculated from our study cohort. Clinicians should be aware that a normal BMO-MRW value and the percent loss for the tipping point may differ from large population-based data. All of the patients in our study population were Asian, so the structure-function relationship may be different in other ethnic populations.
In conclusion, using "broken-stick" analyses, we identified the tipping point between the BMO-MRW and VF sensitivities in this study. Particularly in early glaucoma, functional loss of vision as measured by standard automated perimetry can be masked until significant structural damage has progressed. We suggest that the tipping point is approximately a 25.9% loss from normal global BMO-MRW values. Therefore, the BMO-MRW measurement may help clinicians to make early decisions regarding a reliable treatment plan before any VF abnormality is detected in the early phases of glaucomatous damage.
